Enabling the Use of Digital Tools for People with Varying Physical Abilities and Experience with…
Beaverton, OR, USA, June 29, 2022 – As society becomes increasingly dependent on IoT devices,…
(29th June 2022, Arvada, CO, USA) Leading nanometer-level motion control solutions innovator ALIO Industries, is…
Newly Issued Patent Broadens Medical Uses of Oral APX3330 Therapy in Patients with Diabetes and…
JERSEY, Channel Islands, June 29, 2022 (GLOBE NEWSWIRE) — Quotient Limited (Nasdaq: QTNT) (the “Company”),…
Completion of enrollment for Phase 3 study targeted within 18-24 months In multiple clinical studies,…
TEL AVIV, Israel, June 29, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (the “Company”…
Read the full announcement in PDF Attachment 2022_24_Financial_calendar_2023
BEDFORD, Mass., June 29, 2022 (GLOBE NEWSWIRE) — Homology Medicines, Inc. (Nasdaq: FIXX), a genetic…
Positive Data for Istaroxime in Early Cardiogenic Shock Brings Notable Interest from Potential Partners WARRINGTON,…
Excellent safety, tolerability and pharmacokinetic profile Robust dose-dependent target engagement as measured by ex vivo…
Board is Committed to Maximizing the Amount of Cash the Company Distributes to Stockholders Decision…
Phase 2 portion designed to identify the optimal dose for the pivotal Phase 3 portion…
Industry veteran brings over two decades of global experience in pharmaceutical, medical devices and biotech…
— HAV implanted in nearly 500 patients with more than 1,000 patient-years of follow up…
Evaluation completed of first dose level in investigator-sponsored study in biochemically recurrent prostate cancer Enrollment…
exoASO-STAT6 is the third engineered exosome candidate generated from Codiak’s engEx® Platform to enter clinical…
SEATTLE and VANCOUVER, British Columbia, June 29, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc….
Rucosopasem was safe and well tolerated Early indications of anti-cancer activity and pulmonary function preservation…
Leverages Mindset’s Platform Technology for Efficient Delivery of CNS Therapeutics TORONTO, June 29, 2022 (GLOBE…